Association of Guideline Complexity With Individuals' Ability to Determine Eligibility for COVID-19 Vaccination

• Type of Material: Article
• Authors: Hanna E Schurr, Emory University; Nicole Luisi, Emory University; Travis Sanchez, Emory University; Benjamin Lopman, Emory University; Heather Bradley, Emory University; Patrick Sullivan, Emory University; Aaron Siegler, Emory University
• Language: English
• Date: 2022-10-04
• Publisher: AMER MEDICAL ASSOC
• Publication Version: Final Published Version
• Copyright Statement: 2022 Schurr EH et al. JAMA Network Open.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1001/jamanetworkopen.2022.34579
• Title of Journal or Parent Work: JAMA NETWORK OPEN
• Volume: 5
• Issue: 10
• Start Page: E2234579
• End Page: E2234579
• Grant/Funding Information: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.; This study was supported by grant 3R01AI143875-02S1 from the National Institute of Allergy and Infectious Diseases (Dr Siegler).; Salesforce donated licenses and system development and the Kaiser Family Foundation provided design contributions.
• Keywords: Medicine, General & Internal; Life Sciences & Biomedicine; General & Internal Medicine; Science & Technology
• Research Categories: Health Sciences, Epidemiology

Abstract

Initial demand for COVID-19 vaccines exceeded early supply, so states created vaccine prioritization guidance. The US Centers for Disease Control and Prevention also released guidance on prioritization.1 We assessed COVID-19 vaccine guideline complexity and the ability of individuals to identify their eligibility.